Top 5 Pharma Stocks with high EBITDA margin

What is EBITDA margin?

Earnings Before Interest, Taxes, Depreciation, and Amortization margin is a financial metric that represents a company's operating profitability as a percentage of its revenue. It is a measure of a company's ability to generate earnings from its core operations.

Suven Pharma

Revenue ₹348 CR EBITDA Margin 50.8%

Natco Pharma

Revenue ₹1141CR EBITDA Margin 47.2%

Concord Biotech

Revenue ₹195 CR EBITDA Margin 37%

Eris Lifesciences

Revenue ₹467CR EBITDA Margin 36.4%

Caplin Point

Revenue ₹395CR EBITDA Margin 34%

Click to know the EBITDA margin of other major Pharma Stocks!!